Amanote Research

Amanote Research

    RegisterSign In

94 Risks for Persistent Patent Ductus Arteriosus (PDA) After Treatment With Indomethacin

Pediatric Research - United States
doi 10.1203/00006450-200409000-00117
Full Text
Open PDF
Abstract

Available in full text

Categories
Child HealthPediatricsPerinatology
Date

September 1, 2004

Authors
V LiebO Genzel-Boroviczény
Publisher

Springer Science and Business Media LLC


Related search

Indomethacin Tocolysis Increases Postnatal Patent Ductus Arteriosus Severity

Pediatrics
Child HealthPediatricsPerinatology
1998English

214 Early Versus Symptomatic Treatment for Patent Ductus Arteriosus (PDA) With Ibuprofen in Preterm Infants

Pediatric Research
Child HealthPediatricsPerinatology
2010English

Treatment of Patent Ductus Arteriosus With Ibuprofen

Archives of Disease in Childhood: Fetal and Neonatal Edition
PediatricsGynecologyPerinatologyObstetricsMedicineChild Health
1997English

Ibuprofen and Indomethacin for the Closure of the Patent Ductus Arteriosus

Medical Express
2016English

Patent Ductus Arteriosus /Pda/ Complicating the “Respirytory Distress Syndrome” /RDS/

Pediatric Research
Child HealthPediatricsPerinatology
1975English

Patent Ductus Arteriosus

2020English

Aspirin Versus Indomethacin Treatment of Patent Ductus Arteriosus in Preterm Infants With Respiratory Distress Syndrome

Pediatric Research
Child HealthPediatricsPerinatology
1995English

Patent Ductus Arteriosus

In Clinical Practice
2018English

Patent Ductus Arteriosus

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy